COCRYSTAL PHARMA, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
COCRYSTAL PHARMA, INC. (COCP) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.00% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-10
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 0.00%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 0.00%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-09-30 was 0.83%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 0.83%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2017 was 0.00%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 0.00%.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 1.11%, a 33.73% increase from fiscal 2012.
- COCRYSTAL PHARMA, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.83%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-10 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2018-03-21 | ||||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-08 | ||||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2017-03-31 | ||||
| 2013-12-31 | 1.11% 10-K · filed 2015-03-31 | 0.83% 10-K · filed 2014-03-31 | |||
| 2013-09-30 | 0.83% 10-Q · filed 2013-11-18 | ||||
| 2013-06-30 | 0.83% 10-Q · filed 2013-08-15 | ||||
| 2013-03-31 | 0.83% 10-Q · filed 2013-05-10 | ||||
| 2012-12-31 | 0.83% 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |